EJNMMI Radiopharmacy and Chemistry (Mar 2025)
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
- S. Spreckelmeyer,
- J. Dasilva,
- C. Decristoforo,
- R. H. Mach,
- J. Passchier,
- G. Carlucci,
- M. Al Qahtani,
- A. Duatti,
- B. T. Cornelissen,
- J. Engle,
- A. Denkova,
- J. J. M. A. Hendrikx,
- Y. Seimbille,
- X. Yang,
- H. Jia,
- M-R. Zhang,
- M. Yang,
- L. Perk,
- P. Caravan,
- P. Laverman,
- Z. Cheng,
- C. Hoehr,
- T. Sakr,
- J. R. Zeevaart
Affiliations
- S. Spreckelmeyer
- Department of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt- Universität zu Berlin, Berlin Institute of Health
- J. Dasilva
- University of Montreal
- C. Decristoforo
- Medical University Innsbruck
- R. H. Mach
- University of Pennsylvania
- J. Passchier
- Invicro London
- G. Carlucci
- University of California
- M. Al Qahtani
- Cyclotron and Radiopharmaceuticals Department, Research & Innovation, King Faisal Specialist Hospital and Research Center
- A. Duatti
- University of Ferrara
- B. T. Cornelissen
- Oxford University
- J. Engle
- University of Wisconsin
- A. Denkova
- Delft University of Technology
- J. J. M. A. Hendrikx
- NKI
- Y. Seimbille
- Erasmus MC
- X. Yang
- Peking University First Hospital
- H. Jia
- Beijing Normal University
- M-R. Zhang
- National Institutes for Quantum Science and Technology
- M. Yang
- Jiangsu Institute of Nuclear Medicine
- L. Perk
- Radboud University Medical Center Nijmegen
- P. Caravan
- Massuchusetts General Hospital, Harvard University
- P. Laverman
- Radboud Medical Center
- Z. Cheng
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- C. Hoehr
- TRIUMF
- T. Sakr
- Egyptian Atomic Energy Authority
- J. R. Zeevaart
- Necsa
- DOI
- https://doi.org/10.1186/s41181-025-00335-w
- Journal volume & issue
-
Vol. 10,
no. 1
pp. 1 – 19
Abstract
Abstract Background The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development and application of radiopharmaceuticals. Main body This selection of highlights provides commentary on 24 different topics selected by each co-authoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first-in-human application of novel radiopharmaceuticals. Conclusion Trends in radiochemistry and radiopharmacy are highlighted. Hot topics cover the entire scope of EJNMMI Radiopharmacy and Chemistry, demonstrating the progress in the research field in many aspects.
Keywords
